THE NEW PHARMA Trademark

Trademark Overview

On Wednesday, July 1, 2009, a trademark application was filed for THE NEW PHARMA with the United States Patent and Trademark Office. The USPTO has given the THE NEW PHARMA trademark a serial number of 77772537. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 15, 2012. This trademark is owned by NanoMedical Systems, Inc.. The THE NEW PHARMA trademark is filed in the Medical Instrument Products category with the following description:

an implantable drug delivery device containing a nanofabricated chip sold without medication for delivery of a wide range of pharmaceuticals
the new pharma

General Information

Serial Number77772537
Word MarkTHE NEW PHARMA
Filing DateWednesday, July 1, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 15, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2009

Trademark Statements

Disclaimer with Predetermined Text"PHARMA"
Goods and Servicesan implantable drug delivery device containing a nanofabricated chip sold without medication for delivery of a wide range of pharmaceuticals
Pseudo MarkTHE NEW PHARMACEUTICALS

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, July 7, 2009
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNanoMedical Systems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAustin, TX 787416499
Party NameNanoMedical Systems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 787416499

Trademark Events

Event DateEvent Description
Monday, October 15, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 15, 2012ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 3, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 2, 2012EXTENSION 4 GRANTED
Thursday, February 9, 2012EXTENSION 4 FILED
Thursday, February 9, 2012TEAS EXTENSION RECEIVED
Wednesday, August 31, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 30, 2011EXTENSION 3 GRANTED
Friday, August 26, 2011EXTENSION 3 FILED
Friday, August 26, 2011TEAS EXTENSION RECEIVED
Saturday, February 26, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 25, 2011EXTENSION 2 GRANTED
Wednesday, February 9, 2011EXTENSION 2 FILED
Friday, February 25, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 9, 2011TEAS EXTENSION RECEIVED
Saturday, August 28, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 26, 2010EXTENSION 1 GRANTED
Thursday, August 26, 2010EXTENSION 1 FILED
Thursday, August 26, 2010TEAS EXTENSION RECEIVED
Tuesday, March 9, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2009PUBLISHED FOR OPPOSITION
Thursday, November 12, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 12, 2009ASSIGNED TO LIE
Wednesday, October 28, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 8, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 8, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 8, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 6, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 6, 2009NON-FINAL ACTION E-MAILED
Tuesday, October 6, 2009NON-FINAL ACTION WRITTEN
Monday, September 28, 2009ASSIGNED TO EXAMINER
Wednesday, July 8, 2009NOTICE OF PSEUDO MARK MAILED
Tuesday, July 7, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 4, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharma delivery medication without wide range pharmaceuticals sold chip drug device